Chronic kidney disease and the cardiovascular system

被引:0
作者
Mann, J. [1 ]
Hilgers, K. F. [2 ]
Veelken, R. [2 ]
Lenhardt, C. [1 ]
Schiffrin, E. L. [3 ]
机构
[1] Klinikum Schwabing, Klin Nieren Hochdruck & Rheumakrankheiten, D-80804 Munich, Germany
[2] Univ Erlangen Nurnberg, Med Klin 4, Erlangen, Germany
[3] McGill Univ, Dept Med, Sir Mortimer B Davis Jewish Gen Hosp, Montreal, PQ, Canada
来源
INTERNIST | 2008年 / 49卷 / 04期
关键词
chronic kidney disease; cardiovascular risk; albuminuria; atherosclerosis; endothelial dysfunction;
D O I
10.1007/s00108-008-2092-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Depending on the reduction in glomerular filtration rate (GFR) as a measure of renal insufficiency and depending on their age, patients with chronic kidney disease have a 1.5 to 1,000-fold higher cardiovascular risk. Renal insufficiency is inherently an independent risk factor for cardiovascular events, which is likewise the case for patients also presenting with hypertension or diabetes mellitus. When cardiac insufficiency or coronary heart disease is already manifest, the GFR is the most important predictive factor for the patients' further survival. Proteinuria or albuminuria as signs of kidney disease are also important markers and correlate with the cardiovascular risk in the range of both macro- and microalbuminuria. Endothelial dysfunction, oxidative stress, dyslipidemia, and increased atherosclerosis are being discussed as pathophysiological mechanisms of elevated cardiovascular risk.
引用
收藏
页码:413 / +
页数:7
相关论文
共 22 条
  • [1] Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy
    de Zeeuw, D
    Remuzzi, G
    Parving, HH
    Keane, WF
    Zhang, ZX
    Shahinfar, S
    Snapinn, S
    Cooper, ME
    Mitch, WE
    Brenner, BM
    [J]. CIRCULATION, 2004, 110 (08) : 921 - 927
  • [2] Endothelial dysfunction
    Endemann, DH
    Schiffrin, EL
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (08): : 1983 - 1992
  • [3] Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    Go, AS
    Chertow, GM
    Fan, DJ
    McCulloch, CE
    Hsu, CY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) : 1296 - 1305
  • [4] Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population
    Hillege, HL
    Fidler, V
    Diercks, GFH
    van Gilst, WH
    de Zeeuw, D
    van Veldhuisen, DJ
    Gans, ROB
    Janssen, WMT
    Grobbee, DE
    de Jong, PE
    [J]. CIRCULATION, 2002, 106 (14) : 1777 - 1782
  • [5] Renal function, neurohormonal activation, and survival in patients with chronic heart failure
    Hillege, HL
    Girbes, ARJ
    de Kam, PJ
    Boomsma, F
    de Zeeuw, D
    Charlesworth, A
    Hampton, JR
    van Veldhuisen, DJ
    [J]. CIRCULATION, 2000, 102 (02) : 203 - +
  • [6] Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients -: Losartan intervention for endpoint reduction in hypertension study
    Ibsen, H
    Olsen, MH
    Wachtell, K
    Borch-Johnsen, K
    Lindholm, LH
    Mogensen, CE
    Dahlöf, B
    Devereux, RB
    de Faire, U
    Fyhrquist, F
    Julius, S
    Kjeldsen, SE
    Lederballe-Pedersen, O
    Nieminen, MS
    Omvik, P
    Oparil, S
    Wan, Y
    [J]. HYPERTENSION, 2005, 45 (02) : 198 - 202
  • [7] Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention
    Levin, A
    Singer, J
    Thompson, CR
    Ross, H
    Lewis, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (03) : 347 - 354
  • [8] Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease
    Mann, JFE
    Yi, QL
    Gerstein, HC
    [J]. KIDNEY INTERNATIONAL, 2004, 66 : S59 - S62
  • [9] Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial
    Mann, JFE
    Gerstein, HC
    Pogue, J
    Bosch, J
    Yusuf, S
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) : 629 - 636
  • [10] Microalbuminuria and coronary heart disease in NIDDM - An incidence study
    Mattock, MB
    Barnes, DJ
    Viberti, G
    Keen, H
    Burt, D
    Hughes, JM
    Fitzgerald, AP
    Sandhu, B
    Jackson, PG
    [J]. DIABETES, 1998, 47 (11) : 1786 - 1792